Resource center

Press Release

Genovac Enters Exclusive Licensing Agreement with Pfizer for Therapeutic Antibody Candidates

Pfizer to obtain exclusive worldwide rights to develop and commercialize antibodies from Genovac academic collaboration Fargo, North Dakota, USA, September…

September 19, 2023

View

Press Release

Public-Private Collaboration Takes Aim at Hard-to-Target Cancers

Fargo, N.D., USA (3/13/2023) – Genovac, a Fargo based contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures…

March 13, 2023

View